Kamada, S., Shimono, A, Shinto, Y., Tsujimura, T., Takahashi, T., Noda, T., Kitamura, Y., Kondoh, H. and Tsujimoto, Y.: Bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation and distorted small intestine. Cancer Res. 55, 354-359, 1995

Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H. and Tsujimoto, Y.: Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature, 374, 811-813, 1995

Ikegaki, N., Katsumata, M., Tsujimoto, Y., Nakagawara, A. and Brodeur, G.M.: Relationship between bcl-2 and myc gene expression in human neuroblastoma. Cancer Lett. 91, 161-168, 1995

Miyazaki, T., Liu, Z.-J., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E. L., Perlmutter, R. M. and Taniguchi, T.: Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell, 81, 223-231, 1995

Akao, Y., Marukawa, O., Morikawa, H., Nakao, K., Kamei, M., Hachiya, T. and Tsujimoto, Y.: The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Res. 55, 3444-3449, 1995

Shinto, Y., Morimoto, M., Katsumata, M., Uchida, A., Aozasa, K., Okamoto, M., Kurosawa, T., Ochi, T., Greene, M.I. and Tsujimoto, Y.: Moloney murine leukemia virus infection accelerates lymphomagenesis in Em-bcl-2 trasngenic mice. Oncogene, 11, 1729-1736, 1995

Koseki, T., Yamato, K., Krajewski, S., Reed, J., Tsujimoto, Y. and Nishimura, T. Activin A-induced apoptosis is suppressed by Bcl-2. FEBS Letter, 376, 247- 250, 1995